Last reviewed · How we verify
Nepafenac and lubricant — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Nepafenac and lubricant (Nepafenac and lubricant) — Instituto de Oftalmología Fundación Conde de Valenciana.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nepafenac and lubricant TARGET | Nepafenac and lubricant | Instituto de Oftalmología Fundación Conde de Valenciana | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nepafenac and lubricant CI watch — RSS
- Nepafenac and lubricant CI watch — Atom
- Nepafenac and lubricant CI watch — JSON
- Nepafenac and lubricant alone — RSS
Cite this brief
Drug Landscape (2026). Nepafenac and lubricant — Competitive Intelligence Brief. https://druglandscape.com/ci/nepafenac-and-lubricant. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab